Trial Profile
A retrospective, observation study of Tigecycline for the treatment of Complicated Intra-Abdominal Infections (Ciais): real world study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 01 Dec 2018
Price :
$35
*
At a glance
- Drugs Tigecycline (Primary)
- Indications Intra-abdominal infections
- Focus Therapeutic Use
- 01 Dec 2018 New trial record
- 14 Nov 2018 Results assessing efficacy Tigecycline in patients with of Complicated Intra-Abdominal Infections, presented at the 21st Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research.